866-997-4948(US-Canada Toll Free)

The global cancer market is projected to register a telling growth in the next few years due to the increasing survival chances supported by the application of innovative therapies that work toward the reduction of risks and early detection. Although the survival rates of cancer patients, according to the American Cancer Society (ACS), have dramatically improved over the last two decades, approximately 700,000 deaths and 1.7 mn new cases have been estimated for 2017 by an annual report.

Companies such as Clovis Oncology, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Pfizer Inc., and TapImmune, Inc. are prognosticated to pursue the development of effective therapies that carry the potential to improve survival rates for cancer patients. Top cancer markets such as cancer supportive care therapeutics, cancer immunotherapy, and oncology drugs could witness a significant rise in the near future.

Our all-encompassing depository of market intelligence reports offers broad and profound studies of different cancer and oncology markets featuring cutting-edge analysis and in-depth research.